用阿尼芬净成功治疗婴儿期起病的干扰素基因刺激因子相关血管病（SAVI）综合征 - Suppr

Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.

作者信息

Mansilla-Polo Miguel, Martín-Torregrosa Daniel, Escutia-Muñoz Begoña, Torres-Navarro Ignacio, Saro-Buendía Miguel, Botella-Estrada Rafael

机构信息

Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.

出版信息

JAMA Dermatol. 2024 Aug 1;160(8):899-901. doi: 10.1001/jamadermatol.2024.2160.

DOI:10.1001/jamadermatol.2024.2160

PMID:38985484

Abstract

摘要

相似文献

Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.用阿尼芬净成功治疗婴儿期起病的干扰素基因刺激因子相关血管病（SAVI）综合征

JAMA Dermatol. 2024 Aug 1;160(8):899-901. doi: 10.1001/jamadermatol.2024.2160.

Stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI syndrome).婴儿期起病的干扰素基因相关血管病激发因子（SAVI综合征）

Eur Ann Otorhinolaryngol Head Neck Dis. 2025 Sep;142(5):244-246. doi: 10.1016/j.anorl.2024.11.008. Epub 2024 Dec 9.

Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.干扰素基因刺激物相关血管病伴婴儿期起病：儿童肉芽肿伴多血管炎的类似物。

JAMA Dermatol. 2015 Aug;151(8):872-7. doi: 10.1001/jamadermatol.2015.0251.

Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies.I型干扰素病患者中 IFNAR1 阻断抗体（阿尼鲁单抗）的标准化干扰素特征和临床改善。

J Clin Immunol. 2024 Oct 23;45(1):31. doi: 10.1007/s10875-024-01826-2.

STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.婴儿期起病的STING相关性血管病：一项家族性病例系列报告及文献综述

Ann Transl Med. 2021 Jan;9(2):176. doi: 10.21037/atm-20-6198.

STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.婴儿期起病的STING相关血管病（SAVI）伴皮肤损害。

Pediatr Dermatol. 2024 Sep-Oct;41(5):893-896. doi: 10.1111/pde.15620. Epub 2024 Apr 29.

Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis.干扰素基因相关血管病伴婴儿起病，在作为幼年特发性关节炎治疗过程中出现非典型肺部病变后诊断。

Intern Med. 2021 Apr 1;60(7):1109-1114. doi: 10.2169/internalmedicine.5305-20. Epub 2020 Nov 9.

Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports.婴儿期起病的干扰素基因刺激因子相关血管病：病例报告的系统评价

Front Pediatr. 2020 Dec 17;8:577918. doi: 10.3389/fped.2020.577918. eCollection 2020.

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy.在一名患有婴儿期起病的与STING相关的血管病且对JAK抑制剂和达祖基巴特治疗无效的患者中，使用阿尼鲁单抗持续抑制干扰素特征。

Arthritis Rheumatol. 2025 Feb 25;77(8):1087-91. doi: 10.1002/art.43145.

Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.隐性 STING 相关血管病伴婴儿期起病的表型谱：四例新病例及对既往报道病例的分析。

Front Immunol. 2022 Oct 6;13:1029423. doi: 10.3389/fimmu.2022.1029423. eCollection 2022.

引用本文的文献

Post-marketing safety signals of anifrolumab in systemic lupus erythematosus: a pharmacovigilance study based on FAERS.阿尼鲁单抗在系统性红斑狼疮中的上市后安全信号：一项基于FAERS的药物警戒研究

BMC Rheumatol. 2025 Jul 21;9(1):90. doi: 10.1186/s41927-025-00545-4.

The pathogenesis, clinical presentations and treatment of monogenic systemic vasculitis.单基因系统性血管炎的发病机制、临床表现及治疗

Nat Rev Rheumatol. 2025 May 14. doi: 10.1038/s41584-025-01250-9.

Anifrolumab: the new frontier in the treatment of genetic interferonopathies.阿尼鲁单抗：遗传性干扰素病治疗的新前沿。

RMD Open. 2024 Sep 23;10(3):e004780. doi: 10.1136/rmdopen-2024-004780.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献